{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-208187","form_type":"8-K","ticker":"PRLD","cik":"0001678660","company_name":"Prelude Therapeutics Inc","filed_at":"2025-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.617726+00:00","generated_at":"2026-05-17T06:07:07.086472+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Prelude Therapeutics regains Nasdaq minimum bid price compliance as of Sept 18, 2025","bullets":["Received Nasdaq non-compliance notice on March 27, 2025 for failing $1.00 bid price requirement.","On September 18, 2025, Nasdaq confirmed compliance with Listing Rule 5550(a)(2) and closed the matter.","Common stock (PRLD) remains listed on Nasdaq Global Select Market with bid price issue resolved."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-208187","json":"https://secwatch.observer/filing/0001193125-25-208187.json","markdown":"https://secwatch.observer/filing/0001193125-25-208187.md","text":"https://secwatch.observer/filing/0001193125-25-208187.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1678660/000119312525208187/0001193125-25-208187-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1678660/000119312525208187/prld-20250918.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:07:07.086472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}